首页> 外国专利> Method for predicting the risk of recurrence or malignization of precancerous process of the neck of uterus

Method for predicting the risk of recurrence or malignization of precancerous process of the neck of uterus

机译:预测子宫颈癌前过程复发或恶变的风险的方法

摘要

The invention relates to medicine, particularly to oncologic morphopathology and can be used for predicting the risk of recurrence or malignization of precancerous process of the neck of uterus using the immunologic double staining with antibodies anti-CD105 and anti-Ki67.Summary of the invention consists in the fact that after ionization of precancerous process of the neck of uterus there are prepared histological sections from biopsies of a thickness of 3 µm, they are stained with hematoxylin-eosin, afterwards there are carried out the reactions of immune staining with the antibody anti-CD105, clone SN6h, with staining in brown of the activated vascular endothelium, then with the antibody anti-Ki67, clone MIB1, with staining in red of the nuclei of endothelial cells and if it is determined 0…4 vessels with positive reaction to both antibodies, it is predicted a minimal risk of recurrence or malignization of precancerous process, and if it is determined more than 4 vessels, it is predicted an increased risk of recurrence or malignization of precancerous process.
机译:本发明涉及药物,尤其涉及肿瘤形态病理学,并且可以通过使用抗CD105和抗Ki67抗体的免疫双重染色来预测子宫颈部癌前过程的复发或恶性化的风险。在子宫颈部癌前过程电离后,从活检组织中制备厚度为3 µm的组织切片,然后用苏木精-伊红染色,然后进行抗抗体免疫染色反应。 -CD105,克隆SN6h,被激活的血管内皮细胞染成褐色,然后被抗Ki67抗体,克隆MIB1,被内皮细胞核红色染成,如果确定0…4个血管对两种抗体都可以预测癌前过程复发或恶变的风险最小,如果确定超过4个血管,则认为导致癌前过程复发或恶变的风险增加。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号